324. Methylglutaconic aciduria Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 4 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 10
| Other names | - | ||
|---|---|---|---|
| Disease group | Metabolic diseases | ||
|
Domestic patients
Med expenses recipients (FY2023) |
1 patient Age distribution
 💬 |
||
| Related info (in Japanese) | - | ||
| Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 324-01, 324-02, 324-03 | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 8-2-28. Methylglutaconic aciduria | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 324-1. | 3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I; | 8-2-28. Methylglutaconic aciduria | |
| 324-2. | Barth syndrome;3-MGA type II; | 8-2-28. Methylglutaconic aciduria | |
| 324-3. | Costeff syndrome;3-MGA type III; | 8-2-28. Methylglutaconic aciduria | |
| 324-4. | Mitochondrial respiratory chain disorder;3-MGA type IV; | 8-2-28. Methylglutaconic aciduria | |
| 324-5. | Dilated cardiomyopathy with ataxia syndrome;DCMA syndrome;3-MGA type V; | 8-2-28. Methylglutaconic aciduria | |